IONIQ HEALTH
DEAD

Serial Number

88658162

Owner

MODA PARTNERS, INC.

Attorney

ERNEST G. BOOTSMA

Filing Date

Oct 17, 2019

Add to watchlist:

No watchlists yet
View on USPTO

IONIQ HEALTH Trademark

Serial Number: 88658162

IONIQ HEALTH is a trademark filed by MODA PARTNERS, INC. on October 17, 2019. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

MODA PARTNERS, INC. (9 trademarks)

601 S.W. SECOND AVENUE
PORTLAND, OR 97204

Entity Type: 03

Trademark Details

Filing Date

October 17, 2019

Registration Date

Not Registered

Published for Opposition

April 6, 2021

Goods & Services

pharmaceutical benefit management services; reimbursement payment processing in the field of pharmaceutical claims; providing financial information relating to drug pricing and actuarial services to others; pharmacy network management in the nature of monitoring financial performance of pharmacies

Pharmacy business services in the nature of pharmaceutical cost management services and drug utilization review services, management services provided to pharmacies for controlling drug inventories, business administration of drug reimbursement programs and services, managed care services, namely, drug utilization review and pre-certification services; drug utilization review in the nature of health care utilization and review services, pharmaceutical cost management services and drug utilization review services, duplication of drug therapy; providing pharmaceutical data and analytics to others in the nature of analyzing pharmacy claims data to present cost and utilization trend information, projecting drug spending, modeling rebate scenarios and opportunities, conducting repricing analyses, evaluating the performance of clinical pharmacy programs; business administration services, namely, pharmacy network management in the nature of coordination of medication fulfillment to appropriate pharmacy types, coordination of retail, mail, online, and specialty pharmacies to establish pharmacy networks which can be accessed by providers, patients, and members, coordination and support of the delivery of pharmacy services of ambulatory infusion centers, durable medical equipment, prosthetics, orthotics, and medical supplies containing an assigned National Drug Code product identifier; pharmacy business investigations in the nature of contract compliance and fraud, waste, and abuse investigations; professional pharmacy credentialing verification services in the field of health, namely, verifying the skills and knowledge of pharmacists on behalf of others, and conducting audits

medication therapy management services in the nature of medication compliance and medication counseling

drug utilization review in the nature of providing educational information for proper medication utilization to medical, pharmaceutical, and dental providers and members; medical research in the nature of drug utilization review for drug interactions, duplication of drug therapy, contraindications; medical research, namely, drug utilization review in the nature of drug interactions and contraindications

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 12, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 8, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 20, 2023 EXRA
SOU EXTENSION 5 GRANTED
Dec 19, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 19, 2023 AITU
SOU EXTENSION 5 FILED
Nov 30, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 30, 2023 EEXT
ASSIGNED TO EXAMINER
Nov 6, 2023 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 1, 2023 EXRA
SOU EXTENSION 4 GRANTED
May 30, 2023 EX4G
SOU EXTENSION 4 FILED
May 30, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
May 30, 2023 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 17, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 17, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 17, 2023 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 12, 2022 EXRA
SOU EXTENSION 3 GRANTED
Nov 10, 2022 EX3G
SOU EXTENSION 3 FILED
Nov 10, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 10, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 15, 2022 EXRA
SOU EXTENSION 2 GRANTED
Apr 13, 2022 EX2G
SOU EXTENSION 2 FILED
Apr 13, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 13, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 2, 2021 EXRA
SOU EXTENSION 1 GRANTED
Oct 29, 2021 EX1G
SOU EXTENSION 1 FILED
Oct 29, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 29, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 1, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 6, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 25, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 25, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 25, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 25, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 17, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 18, 2020 GNFN
FINAL REFUSAL E-MAILED
Aug 18, 2020 GNFR
FINAL REFUSAL WRITTEN
Aug 18, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 28, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 27, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 27, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 26, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jan 26, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jan 26, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 23, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2019 NWOS
NEW APPLICATION ENTERED
Oct 21, 2019 NWAP